RESONAT-2 Trial Predictions for Patients With CLL

Upcoming RESONAT-2 trial results for patients with chronic lymphocytic leukemia (CLL). William G. Weirda, MD, PhD, medical director of the Leukemia Center at The University of Texas MD Anderson Cance... Author: onclivetv Added: 03/23/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts